We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

ITC To Investigate Roche At Amgen's Behest

Law360 (May 9, 2006, 12:00 AM EDT) -- In a move signifying a boon for Amgen Inc. and a threat to the proposed sales of Hoffman-La Roche Inc.'s anti-anemia drug C.E.R.A. in the U.S., the U.S. International Trade Commission...
To view the full article, register now.